Description
Additional file 1. Supplementary information.
| Date made available | 2019 |
|---|---|
| Publisher | Figshare |
Cite this
- DataSetCite
MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
- Ssu Chuan Lai (Contributor)
- Yu-Chih Wu (Contributor)
- Ching Chi Chi (Contributor)
- Pei Chi Lan (Contributor)
- Kam Fai Lee (Contributor)
- Muh Hwa Yang (Contributor)
- Yu Ting Su (Creator)
- Te Sheng Chang (Contributor)
- YungChe Kuo (Contributor)
- Yen-Hua Huang (Contributor)
- TMU Research Center of Cell Therapy and Regeneration Medicine
- TMU Research Center of Thoracic Medicine
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- TMU Research Center of Cancer Translational Medicine
- International Master Program in Medicine
- The Ph.D. Program for Translational Medicine
- Department of Biochemistry and Molecular Cell Biology
Dataset